Precision Therapeutics to Present Abstracts at AACR Meeting
April 16, 2010
Precision Therapeutics will present two abstracts at the upcoming American Association for Cancer Research (AACR) meeting in Washington, DC, April 17-21. Results described in both abstracts/posters indicate the potential utility of ChemoFx® and gene expression analysis in predicting individual patient response to chemotherapy. Learn more at www.chemofx.com.
« Imago Acquired by AMETEK | | Carnegie Learning Introduces Geometry Second Edition »
